Capstone Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $232K | Buy |
+2,909
| New | +$232K | 0.01% | 1431 |
|
|
2016
Q1 | – | Sell |
-2,559
| Closed | -$241K | – | 1581 |
|
|
2015
Q4 | $241K | Buy |
+2,559
| New | +$241K | 0.01% | 1411 |
|
|
2015
Q3 | – | Sell |
-1,749
| Closed | -$210K | – | 1594 |
|
|
2015
Q2 | $210K | Buy |
+1,749
| New | +$210K | 0.01% | 1506 |
|
|
2013
Q4 | – | Sell |
-5,351
| Closed | -$343K | – | 1875 |
|
|
2013
Q3 | $343K | Buy |
+5,351
| New | +$343K | 0.01% | 1571 |
|